Features Pricing Learn Reverse Splits Tracker Shelf & ATM Tracker Warrant Tracker PIPE Deal Tracker Weekly Report FAQ API Sign In →
63 /100
HIGH RISK
Score updated Aug 28, 2026

NMTC — NeuroOne Medical Technologies Corporation Dilution Risk Tracker

Track NMTC dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track NMTC — Get alerts when the score changes →

As of August 28, 2026, NeuroOne Medical Technologies Corporation (NMTC) has a DilutionWatch DilutionScore of 63/100, rated HIGH dilution risk. NeuroOne Medical Technologies Corporation has a market capitalization of $30.60M, 9.11M shares outstanding, 34 institutional holders tracked.

This page includes automatically generated factual summaries from DilutionWatch data. It is not financial advice, not investment research, and not a recommendation. Do your own research. Read the full disclaimer and terms of service.

Score Breakdown

📋 Offering Ability
46
💰 Cash Runway
85
📊 Float Risk
27
⚠️ Warrant Exposure
40
🔄 Convertible Debt
85

Dilution Forecast

⛈️
Warning
High probability of dilution event
model est. 43%
🔁 Convertible Conversion model 60%
• Major convertible overhang: 22520% potential dilution
• Convertible risk score very high (85/100)
💰 Capital Raise model 35%
• Low cash runway: 4 months remaining
🔄 Reverse Split model est. 15%
• Only 4 months cash — financial pressure
🔔 Track NMTC — Get forecast alerts →

Market Data

Market Cap$30.60M
Shares Outstanding9.11M
Float7.82M
Cash$3.04M
Debt$121.9K
Short InterestN/A

Institutional Holdings

QoQ: ↑ 6.3% shares (2026Q1 vs prior)
34 institutional holders · 13.36M shares
#1 Bleichroeder LP 4.00M shares
#2 VANGUARD CAPITAL MANAGEMENT LLC 2.79M shares
#3 BARD ASSOCIATES INC 1.84M shares
+ 17 more holders Sign up free to view →

Institutional holder totals are aggregated from ownership filings and may use a different share basis or reporting date than public float. They are not a reconciliation against tradeable float.

Short Interest

Short Interest38.7K
Days to Cover1.1
% of Float0.5%
FINRA data as of Jul 31, 2026

Recent SEC Activity

xbrl XBRL WARRANT 2025-09-30
xbrl XBRL CONVERTIBLE 2021-09-30
4 INSIDER TRANSACTION 2026-04-07
4 INSIDER TRANSACTION 2026-04-07
4 INSIDER TRANSACTION 2026-04-07
Full SEC filing analysis available with free account

Recent News

No recent news

Factual NMTC Dilution Snapshot

NeuroOne Medical Technologies Corporation (NMTC) has a DilutionScore of 63/100, rated High dilution risk. Score date: August 28, 2026.

This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.

Track NMTC Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking NMTC — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required

Related Stocks — HIGH Risk

Other HIGH dilution risk stocks tracked by DilutionWatch with similar profiles:

→ Biotech / Pharma sector dilution risk overview

Browse all 8,024+ tracked stocks →

📖 Dilution Education
→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations
More Research for NMTC
NMTC FDA Catalyst Timeline & Biotech Grade — BiotechSigns

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.